108 related articles for article (PubMed ID: 6585590)
1. Antitumor effect, cardiotoxicity, and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing LOU/M/WSL rat.
van Hoesel QG; Steerenberg PA; Vos JG; Hillen FC; Dormans JA
J Natl Cancer Inst; 1984 May; 72(5):1141-50. PubMed ID: 6585590
[TBL] [Abstract][Full Text] [Related]
2. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.
van Hoesel QG; Steerenberg PA; Dormans JA; de Jong WH; de Wildt DJ; Vos JG
J Natl Cancer Inst; 1986 Feb; 76(2):299-307. PubMed ID: 3456068
[TBL] [Abstract][Full Text] [Related]
3. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC
Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of doxorubicin-induced toxicity in the intact Lou/M Wsl rat and in isolated heart preparations.
de Wildt DJ; de Jong Y; Hillen FC; Steerenberg PA; van Hoesel QG
J Pharmacol Exp Ther; 1985 Oct; 235(1):234-40. PubMed ID: 4045723
[TBL] [Abstract][Full Text] [Related]
6. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.
Storm G; van Hoesel QG; de Groot G; Kop W; Steerenberg PA; Hillen FC
Cancer Chemother Pharmacol; 1989; 24(6):341-8. PubMed ID: 2791187
[TBL] [Abstract][Full Text] [Related]
8. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats.
Ibrahim MA; Morsy MA; Hafez HM; Gomaa WM; Abdelrahman AM
Toxicol Mech Methods; 2012 Jul; 22(6):424-31. PubMed ID: 22394338
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
Puri A; Maulik SK; Ray R; Bhatnagar V
Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
[TBL] [Abstract][Full Text] [Related]
13. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.
Anjos Ferreira AL; Russell RM; Rocha N; Placido Ladeira MS; Favero Salvadori DM; Oliveira Nascimento MC; Matsui M; Carvalho FA; Tang G; Matsubara LS; Matsubara BB
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):16-24. PubMed ID: 17577311
[TBL] [Abstract][Full Text] [Related]
14. Effects of S-adenosylmethionine (SAMe) on doxorubicin-induced cardiotoxicity in the rat.
Russo S; Filippelli W; Ferraraccio F; Berrino L; Guarino V; Rossi F
J Med; 1994; 25(1-2):65-89. PubMed ID: 7930959
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
16. Circadian rhythm in Bence-Jones protein excretion by LOU rats bearing a transplantable immunocytoma, responsive to adrimycin treatment.
Nelson W; Zinneman H; Selden J; Schaper K; Halberg F; Bazin H
Int J Chronobiol; 1974; 2(4):359-65. PubMed ID: 4219403
[No Abstract] [Full Text] [Related]
17. Effect of angiotensin II on the antitumor activity and cardiotoxicity of doxorubicin.
Monti E; Paracchini L; Piccinini F; Rossi C; Formelli F
Cancer Lett; 1990 Apr; 50(1):79-85. PubMed ID: 2353985
[TBL] [Abstract][Full Text] [Related]
18. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
[TBL] [Abstract][Full Text] [Related]
19. Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice.
Osman AM; Nemnem MM; Abou-Bakr AA; Nassier OA; Khayyal MT
Food Chem Toxicol; 2009 Oct; 47(10):2425-30. PubMed ID: 19577608
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]